Publications

Publications from OUS - Section for sarcoma and melanoma

414 publications found

Publications 2022

1. Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
   Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
   Anticancer Res, 42 (2), 955-963
   DOI 10.21873/anticanres.15555, PubMed 35093895
2. Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
   Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
   Oncotarget, 13, 508-517
   DOI 10.18632/oncotarget.28209, PubMed 35284037
3. Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
   Fibrinogen-like protein 2 in gastrointestinal stromal tumour
   J Cell Mol Med, 26 (4), 1083-1094
   DOI 10.1111/jcmm.17163, PubMed 35029030

Publications 2021

1. Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
   Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
   Cancer Immunol Immunother, 70 (9), 2617-2624
   DOI 10.1007/s00262-021-02876-w, PubMed 33580363
2. Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
   Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
   Ann Oncol, 33 (1), 20-33
   DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
3. Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
   Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
   Cancers (Basel), 13 (16)
   DOI 10.3390/cancers13164076, PubMed 34439229
4. Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
   Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
   Pathology, 53 (6), 713-719
   DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
5. Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
   Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
   NPJ Digit Med, 4 (1), 33
   DOI 10.1038/s41746-021-00398-4, PubMed 33619361
6. Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
   Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
   Eur J Cancer, 151, 150-158
   DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
7. Hølmebakk T, Boye K (2021)
   ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
   Ann Surg Oncol, 28 (11), 6846-6847
   DOI 10.1245/s10434-021-09608-5, PubMed 33687615
8. Hølmebakk T, Boye K (2021)
   Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
   Ann Surg Oncol, 28 (Suppl 3), 873
   DOI 10.1245/s10434-021-09939-3, PubMed 33829360
9. Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
   Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
   Ann Surg Oncol, 28 (11), 6837-6845
   DOI 10.1245/s10434-021-09605-8, PubMed 33651216
10. Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
    Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
    Cancers (Basel), 13 (4)
    DOI 10.3390/cancers13040779, PubMed 33668474
11. Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
    Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
    Acta Vet Scand, 63 (1), 41
    DOI 10.1186/s13028-021-00608-9, PubMed 34732227
12. Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
    Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
    JAMA Oncol, 7 (1), e205865
    DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
13. Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
    Metastases in locally advanced rectal cancer undergoing curatively intended treatment
    Eur J Surg Oncol, 47 (9), 2377-2383
    DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
14. Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
    Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
    Clin Transl Radiat Oncol, 28, 39-47
    DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
15. Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
    Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
    PLoS One, 16 (3), e0248133
    DOI 10.1371/journal.pone.0248133, PubMed 33662039
16. Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
    Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
    Nat Commun, 12 (1), 3230
    DOI 10.1038/s41467-021-23445-w, PubMed 34050156
17. Revheim ME, Hole KH, Mo T, Bruland ØS, Reitan E, Julsrud L, Seierstad T (2021)
    Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
    Acta Radiol, 02841851211027389
    DOI 10.1177/02841851211027389, PubMed 34171968
18. Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S (2021)
    Cancer therapy with isolated limb perfusion
    Tidsskr Nor Laegeforen, 141 (2021-12)
    DOI 10.4045/tidsskr.21.0194, PubMed 34505491
19. Stenberg VY, Larsen RH, Ma LW, Peng Q, Juzenas P, Bruland ØS, Juzeniene A (2021)
    Evaluation of the PSMA-Binding Ligand ²¹²Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer
    Int J Mol Sci, 22 (9)
    DOI 10.3390/ijms22094815, PubMed 34062920
20. Switlyk MD, Niehusmann P, Sprauten M, Magelssen H, Aarhus M, Rasmussen FØ, Knutstad K, Brandal P (2021)
    Neurosarcoidosis resembling multiple meningiomas: A misleading presentation of the disease and diagnostic challenge
    Acta Radiol Open, 10 (7), 20584601211036550
    DOI 10.1177/20584601211036550, PubMed 34377543
21. Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM et al. (2021)
    Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma
    Acta Oncol, 61 (2), 235-238
    DOI 10.1080/0284186X.2021.2022202, PubMed 34970940
22. van Eck I, den Hollander D, Lidington E, Hentschel L, Eichler M, Salah S, Singer S, Pinto M, Fauske L, Fiore M, Nixon I, Constantinidou A, Desar IME, Bonenkamp JJ, van Houdt WJ, Reuvers MJP, Haas RLM, Bruland ØS, Kasper B, van der Graaf WTA, Husson O (2021)
    Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
    J Clin Med, 10 (22)
    DOI 10.3390/jcm10225334, PubMed 34830615
23. Våde L, Hompland I, Fauske L (2021)
    Exploring Mentorship as a Novel Approach to Improving Quality of Life in Sarcoma Survivors: A Qualitative Pilot Study
    Sarcoma, 2021, 2042785
    DOI 10.1155/2021/2042785, PubMed 34421328
24. Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2021)
    MRI pulse sequence integration for deep-learning-based brain metastases segmentation
    Med Phys, 48 (10), 6020-6035
    DOI 10.1002/mp.15136, PubMed 34405896
25. Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK (2021)
    Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up
    Int J Cancer, 150 (1), 100-111
    DOI 10.1002/ijc.33768, PubMed 34449877

Publications 2020

1. Dagenborg VJ, Marshall SE, Yaqub S, Grzyb K, Boye K, Lund-Iversen M, Høye E, Berstad AE, Fretland ÅA, Edwin B, Ree AH, Flatmark K (2020)
   Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases
   Cancer Biol Ther, 21 (5), 432-440
   DOI 10.1080/15384047.2020.1721252, PubMed 32098573
2. Digernes I, Nilsen LB, Grøvik E, Bjørnerud A, Løvland G, Vik-Mo E, Meling TR, Saxhaug C, Helland Å, Jacobsen KD, Geier O, Emblem KE (2020)
   Noise dependency in vascular parameters from combined gradient-echo and spin-echo DSC MRI
   Phys Med Biol, 65 (22), 225020
   DOI 10.1088/1361-6560/abb71a, PubMed 33200748
3. Fauske L, Hompland I, Lorem G, Hall KS, Bondevik H (2020)
   Striving towards Normality in Daily Life: A Qualitative Study of Patients Living with Metastatic Gastrointestinal Stromal Tumour in Long-Term Clinical Remission
   Sarcoma, 2020, 1814394
   DOI 10.1155/2020/1814394, PubMed 33082706
4. Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
   Soluble AXL as a marker of disease progression and survival in melanoma
   PLoS One, 15 (1), e0227187
   DOI 10.1371/journal.pone.0227187, PubMed 31917795
5. Fleten KG, Lund-Andersen C, Waagene S, Abrahamsen TW, Mørch Y, Boye K, Torgunrud A, Flatmark K (2020)
   Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
   Transl Oncol, 13 (8), 100793
   DOI 10.1016/j.tranon.2020.100793, PubMed 32447231
6. Georgiesh T, Boye K, Bjerkehagen B (2020)
   A novel risk score to predict early and late recurrence in solitary fibrous tumour
   Histopathology, 77 (1), 123-132
   DOI 10.1111/his.14078, PubMed 31991494
7. Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M (2020)
   Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study
   Clin Sarcoma Res, 10 (1), 22
   DOI 10.1186/s13569-020-00145-5, PubMed 33292545
8. Hamre CFB, Kvammen EMH, Vinge LE, Skeie AT, Hompland I (2020)
   Sarcoma of the heart
   Tidsskr. Nor. Laegeforen., 140 (6), 582-583
9. Hompland I, Fauske L, Lorem GF, Bruland ØS (2020)
   Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
   Clin Sarcoma Res, 10, 2
   DOI 10.1186/s13569-019-0124-3, PubMed 31969978
10. Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C (2020)
    The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy
    Lancet Child Adolesc Health, 4 (11), 846-852
    DOI 10.1016/S2352-4642(20)30183-8, PubMed 33068550
11. König M, Osnes T, Bruland Ø, Sundby Hall K, Bratland Å, Meling TR (2020)
    The Role of Adjuvant Treatment in Craniofacial Malignancy: A Critical Review
    Front Oncol, 10, 1402
    DOI 10.3389/fonc.2020.01402, PubMed 32850452
12. Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ (2020)
    Prospects for NK Cell Therapy of Sarcoma
    Cancers (Basel), 12 (12)
    DOI 10.3390/cancers12123719, PubMed 33322371
13. Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland ØS, Larsen RH (2020)
    Calibration of sodium iodide detectors and reentrant ionization chambers for ²¹²Pb activity in different geometries by HPGe activity determined samples
    Appl Radiat Isot, 166, 109362
    DOI 10.1016/j.apradiso.2020.109362, PubMed 32979756
14. Nilsen LB, Digernes I, Grøvik E, Saxhaug C, Latysheva A, Geier O, Breivik B, Sætre DO, Jacobsen KD, Helland Å, Emblem KE (2020)
    Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
    Neurooncol Adv, 2 (1), vdaa028
    DOI 10.1093/noajnl/vdaa028, PubMed 32642687
15. Palmerini E, Leithner A, Windhager R, Gosheger G, Boye K, Laitinen M, Hardes J, Traub F, Jutte P, Willegger M, Casanova J, Setola E, Righi A, Picci P, Donati DM, Ferrari S (2020)
    Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS)
    Sci Rep, 10 (1), 10853
    DOI 10.1038/s41598-020-66579-5, PubMed 32616718
16. Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
    Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
    Acta Oncol, 59 (7), 733-740
    DOI 10.1080/0284186X.2020.1742377, PubMed 32208873
17. Stenberg VY, Juzeniene A, Bruland ØS, Larsen RH (2020)
    In situ Generated ²¹²Pb-PSMA Ligand in a ²²⁴Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
    Curr Radiopharm, 13 (2), 130-141
    DOI 10.2174/1874471013666200511000532, PubMed 32389119
18. Stenberg VY, Juzeniene A, Chen Q, Yang X, Bruland ØS, Larsen RH (2020)
    Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [²¹² Pb]Pb-NG001 for prostate cancer
    J Labelled Comp Radiopharm, 63 (3), 129-143
    DOI 10.1002/jlcr.3825, PubMed 31919866

Publications 2019

1. Berner K, Bruland ØS (2019)
   Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas
   Anticancer Res, 39 (5), 2459-2466
   DOI 10.21873/anticanres.13365, PubMed 31092440
2. Fauske L, Bondevik H, Ahlberg K, Bjørndal A (2019)
   Identifying bone sarcoma survivors facing psychosocial challenges. A study of trajectories following treatment
   Eur J Cancer Care (Engl), 28 (5), e13119
   DOI 10.1111/ecc.13119, PubMed 31184795
3. Fauske L, Hompland I, Lorem G, Bondevik H, Bruland ØS (2019)
   Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study
   Clin Sarcoma Res, 9, 6
   DOI 10.1186/s13569-019-0116-3, PubMed 31061697
4. Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G et al. (2019)
   Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group
   Lancet Oncol, 20 (3), e155-e166
   DOI 10.1016/S1470-2045(19)30034-8, PubMed 30842059
5. Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K (2019)
   Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?
   Ann Surg Oncol, 26 (13), 4730-4736
   DOI 10.1245/s10434-019-07813-x, PubMed 31520212
6. Jha AK, Neupane P, Pradhan M, Sharma KS, Shrestha S, Sigdel PR, Smeland S, Bruland ØS (2019)
   Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
   J Glob Oncol, 5, 1-10
   DOI 10.1200/JGO.19.00015, PubMed 30917070
7. Köksal H, Müller E, Inderberg EM, Bruland Ø, Wälchli S (2019)
   Treating osteosarcoma with CAR T cells
   Scand J Immunol, 89 (3), e12741
   DOI 10.1111/sji.12741, PubMed 30549299
8. Namløs HM, Boye K, Meza-Zepeda LA (2019)
   Cell-free DNA in blood as a noninvasive insight into the sarcoma genome
   Mol Aspects Med, 72, 100827
   DOI 10.1016/j.mam.2019.10.004, PubMed 31703948
9. Nyakas M, Aamdal E, Jacobsen KD, Guren TK, Aamdal S, Hagene KT, Brunsvig P, Yndestad A, Halvorsen B, Tasken KA, Aukrust P, Maelandsmo GM, Ueland T (2019)
   Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
   Clin Exp Immunol, 197 (1), 74-82
   DOI 10.1111/cei.13283, PubMed 30821848
10. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 58 (10), 1416-1422
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
11. Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland HK, Børge Johannesen T, Viset T, Norum OJ, Bruland Ø, Zaikova O (2019)
    Chondrosarcoma in Norway 1990-2013; an epidemiological and prognostic observational study of a complete national cohort
    Acta Oncol, 58 (3), 273-282
    DOI 10.1080/0284186X.2018.1554260, PubMed 30632866

Publications 2018

1. Ajithkumar T, Horan G, Padovani L, Thorp N, Timmermann B, Alapetite C, Gandola L, Ramos M, Van Beek K, Christiaens M, Lassen-Ramshad Y, Magelssen H, Nilsson K, Saran F, Rombi B, Kortmann R, Janssens GO, SIOPE BTG Radiotherapy Group (2018)
   SIOPE - Brain tumor group consensus guideline on craniospinal target volume delineation for high-precision radiotherapy
   Radiother Oncol, 128 (2), 192-197
   DOI 10.1016/j.radonc.2018.04.016, PubMed 29729847
2. Berner K, Johannesen TB, Hall KS, Bruland ØS (2018)
   Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study
   J Bone Oncol, 14, 002-2
   DOI 10.1016/j.jbo.2018.11.002, PubMed 30568874
3. Berner K, Zaikova O, Johannesen TB, Hall KS, Bruland ØS (2018)
   Validity and completeness of the Scandinavian Sarcoma Group Central Register by comparison with a nationwide cohort of patients with osteosarcoma in Norway
   J Surg Oncol, 118 (1), 246-247
   DOI 10.1002/jso.25137, PubMed 30208205
4. Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T (2018)
   Genotype and risk of tumour rupture in gastrointestinal stromal tumour
   Br J Surg, 105 (2), e169-e175
   DOI 10.1002/bjs.10743, PubMed 29341147
5. Digernes I, Grøvik E, Nilsen LB, Saxhaug C, Geier O, Reitan E, Sætre DO, Breivik B, Reese T, Jacobsen KD, Helland Å, Emblem KE (2018)
   Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
   Adv Radiat Oncol, 3 (4), 559-567
   DOI 10.1016/j.adro.2018.05.005, PubMed 30370356
6. Frezza AM, Jones RL, Lo Vullo S, Asano N, Lucibello F, Ben-Ami E, Ratan R, Teterycz P, Boye K, Brahmi M, Palmerini E, Fedenko A, Vincenzi B, Brunello A, Desar IME, Benjamin RS, Blay JY, Broto JM, Casali PG, Gelderblom H, Grignani G, Gronchi A, Hall KS, Mir O, Rutkowski P et al. (2018)
   Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series
   JAMA Oncol, 4 (9), e180219
   DOI 10.1001/jamaoncol.2018.0219, PubMed 29800950
7. Heinrich D, Bruland Ø, Guise TA, Suzuki H, Sartor O (2018)
   Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker
   Future Oncol, 14 (24), 2543-2556
   DOI 10.2217/fon-2018-0087, PubMed 29925281
8. Hesla AC, Bruland ØS, Jebsen N, Styring E, Eriksson S, Tsagozis P (2018)
   Ewing sarcoma of the mobile spine; predictive factors for survival, neurological function and local control. A Scandinavian sarcoma group study with a mean follow-up of 12 years
   J Bone Oncol, 14, 100216
   DOI 10.1016/j.jbo.2018.100216, PubMed 30666289
9. Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K (2018)
   Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour
   Br J Surg, 106 (4), 419-426
   DOI 10.1002/bjs.11027, PubMed 30507040
10. Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K (2018)
    Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
    Ann Surg Oncol, 25 (5), 1133-1139
    DOI 10.1245/s10434-018-6353-5, PubMed 29435684
11. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2018)
    Added value of F-18-FDG PET-CT in staging of Ewing sarcoma in children and young adults
    Eur. J. Hybrid Imag., 2 (1), 13
    DOI 10.1186/s41824-018-0031-5
12. Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K (2018)
    Pazopanib in relapsed osteosarcoma patients: report on 15 cases
    Acta Oncol, 58 (1), 124-128
    DOI 10.1080/0284186X.2018.1503714, PubMed 30207179
13. Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA (2018)
    Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor
    Mol Cancer Ther, 17 (11), 2473-2480
    DOI 10.1158/1535-7163.MCT-18-0174, PubMed 30097488
14. Seravalli E, Bosman M, Lassen-Ramshad Y, Vestergaard A, Oldenburger F, Visser J, Koutsouveli E, Paraskevopoulou C, Horan G, Ajithkumar T, Timmermann B, Fuentes CS, Whitfield G, Marchant T, Padovani L, Garnier E, Gandola L, Meroni S, Hoeben BAW, Kusters M, Alapetite C, Losa S, Goudjil F, Magelssen H, Evensen ME et al. (2018)
    Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European centers: analysis on behalf of the SIOP-E-BTG (radiotherapy working group)
    Acta Oncol, 57 (9), 1240-1249
    DOI 10.1080/0284186X.2018.1465588, PubMed 29698060
15. Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M (2018)
    Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX)
    Eur J Cancer, 99, 78-85
    DOI 10.1016/j.ejca.2018.05.011, PubMed 29929092
16. Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE (2018)
    Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study
    J Am Acad Dermatol, 79 (1), 118-125.e1
    DOI 10.1016/j.jaad.2018.03.023, PubMed 29580861
17. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH (2018)
    Therapeutic Effect of α-Emitting ²²⁴Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer
    Transl Oncol, 11 (2), 259-267
    DOI 10.1016/j.tranon.2017.12.011, PubMed 29413758
18. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH (2018)
    Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice
    J Labelled Comp Radiopharm, 61 (6), 472-486
    DOI 10.1002/jlcr.3610, PubMed 29380410

Publications 2017

1. Boye K, Jebsen NL, Zaikova O, Knobel H, Løndalen AM, Trovik CS, Monge OR, Hall KS (2017)
   Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort
   Acta Oncol, 56 (3), 479-483
   DOI 10.1080/0284186X.2016.1278305, PubMed 28105885
2. Egeland EV, Boye K, Park D, Synnestvedt M, Sauer T, Oslo Breast Cancer Consortium (OSBREAC), Naume B, Borgen E, Mælandsmo GM (2017)
   Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
   Breast Cancer Res Treat, 162 (1), 127-137
   DOI 10.1007/s10549-016-4096-1, PubMed 28058579
3. Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K (2017)
   Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort
   Acta Oncol, 56 (10), 1317-1323
   DOI 10.1080/0284186X.2017.1330555, PubMed 28557540
4. Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2017)
   Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
   BMC Cancer, 17 (1), 29
   DOI 10.1186/s12885-016-2992-8, PubMed 28061772
5. Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS et al. (2017)
   Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
   Eur Urol, 73 (3), 427-435
   DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540
6. Pulkka OP, Nilsson B, Sarlomo-Rikala M, Reichardt P, Eriksson M, Hall KS, Wardelmann E, Vehtari A, Joensuu H, Sihto H (2017)
   SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
   Br J Cancer, 116 (9), 1195-1202
   DOI 10.1038/bjc.2017.82, PubMed 28334729
7. Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
   Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
   ESMO Open, 2 (2), e000158
   DOI 10.1136/esmoopen-2017-000158, PubMed 28761742
8. Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C (2017)
   An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223
   Ann Oncol, 28 (5), 1090-1097
   DOI 10.1093/annonc/mdx044, PubMed 28453701
9. Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A (2017)
   Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
   Oncologist, 23 (1), 62-70
   DOI 10.1634/theoncologist.2017-0161, PubMed 28754721

Publications 2016

1. Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA (2016)
   Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
   PLoS One, 11 (9), e0163859
   DOI 10.1371/journal.pone.0163859, PubMed 27685995
2. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
   Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
   Cancer Med, 5 (8), 1840-9
   DOI 10.1002/cam4.766, PubMed 27273130
3. Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
   Expression and clinical significance of Wee1 in colorectal cancer
   Tumour Biol, 37 (9), 12133-12140
   DOI 10.1007/s13277-016-5081-3, PubMed 27220319
4. Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K (2016)
   Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
   Clin Sarcoma Res, 6, 21
   DOI 10.1186/s13569-016-0062-2, PubMed 27999655
5. Johnsen B, Fasmer KE, Boye K, Rosendahl K, Trovik C, Biermann M, Aukland SM (2016)
   Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012
   Pediatr Radiol, 47 (1), 82-88
   DOI 10.1007/s00247-016-3720-x, PubMed 27815616
6. König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR (2016)
   Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years
   Neurosurg Rev, 40 (3), 449-460
   DOI 10.1007/s10143-016-0802-z, PubMed 27858303
7. Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS et al. (2016)
   Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
   Lancet Oncol, 17 (10), 1396-1408
   DOI 10.1016/S1470-2045(16)30214-5, PubMed 27569442
8. Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D (2016)
   Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial
   Eur Urol, 70 (5), 875-883
   DOI 10.1016/j.eururo.2016.06.002, PubMed 27344296
9. Rud AK, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun OT, Mælandsmo GM (2016)
   Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer
   Diagn Pathol, 11 (1), 50
   DOI 10.1186/s13000-016-0504-4, PubMed 27316334
10. Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS (2016)
    Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature
    Clin Sarcoma Res, 6, 2
    DOI 10.1186/s13569-016-0042-6, PubMed 26913180
11. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH (2016)
    Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
    PLoS One, 11 (10), e0165382
    DOI 10.1371/journal.pone.0165382, PubMed 27776176

Publications 2015

1. Anfinsen KP, Grotmol T, Bruland OS, Cathrine T, Jonasdottir TJ (2015)
   Corrigendum to "Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence" [Prev. Vet. Med. 119 (2015) 48-53]
   Prev Vet Med, 120 (2), 252
   DOI 10.1016/j.prevetmed.2015.03.015, PubMed 31159133
2. Anfinsen KP, Grotmol T, Bruland OS, Trangerud C, Jonasdottir TJ (2015)
   Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence
   Prev Vet Med, 119 (1-2), 48-53
   DOI 10.1016/j.prevetmed.2015.02.003, PubMed 25732913
3. Berner K, Bjerkehagen B, Bruland ØS, Berner A (2015)
   Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature
   Anticancer Res, 35 (4), 2129-40
   PubMed 25862869
4. Berner K, Hall KS, Monge OR, Weedon-Fekjær H, Zaikova O, Bruland ØS (2015)
   Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient
   Sarcoma, 2015, 516843
   DOI 10.1155/2015/516843, PubMed 25784831
5. Berner K, Johannesen TB, Bruland ØS (2015)
   Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
   Sarcoma, 2015, 917679
   DOI 10.1155/2015/917679, PubMed 26412976
6. Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM (2015)
   Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
   Clin Exp Metastasis, 32 (8), 755-67
   DOI 10.1007/s10585-015-9742-1, PubMed 26349943
7. Fauske L, Bondevik H, Bruland ØS, Ozakinci G (2015)
   Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study
   Anticancer Res, 35 (11), 6081-90
   PubMed 26504033
8. Fauske L, Bruland OS, Grov EK, Bondevik H (2015)
   Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities
   Sarcoma, 2015, 484196
   DOI 10.1155/2015/484196, PubMed 25949211
9. Fauske L, Lorem G, Grov EK, Bondevik H (2015)
   Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study
   J Surg Oncol, 113 (2), 229-34
   DOI 10.1002/jso.24138, PubMed 26714610
10. Ferrari S, Luksch R, Hall KS, Fagioli F, Prete A, Tamburini A, Tienghi A, DiGirolamo S, Paioli A, Abate ME, Podda M, Cammelli S, Eriksson M, Brach del Prever A (2015)
    Post-relapse survival in patients with Ewing sarcoma
    Pediatr Blood Cancer, 62 (6), 994-9
    DOI 10.1002/pbc.25388, PubMed 25585917
11. Hompland I, Bruland ØS (2015)
    Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
    Anticancer Res, 35 (11), 5759-65
    PubMed 26503996
12. Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS (2015)
    [A boy with a wound on his finger that would not heal]
    Tidsskr Nor Laegeforen, 135 (5), 445-8
    DOI 10.4045/tidsskr.14.0759, PubMed 25761032
13. Hompland I, Rizvi SMH, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mork NJ, Hall KS (2015)
    A boy with a wound on his finger that would not heal
    Tidsskr. Nor. Laegeforen., 135 (5), 444-447
14. Humm JL, Sartor O, Parker C, Bruland OS, Macklis R (2015)
    Radium-223 in the treatment of osteoblastic metastases: a critical clinical review
    Int J Radiat Oncol Biol Phys, 91 (5), 898-906
    DOI 10.1016/j.ijrobp.2014.12.061, PubMed 25832684
15. Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM (2015)
    F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study
    Clin Physiol Funct Imaging, 36 (6), 441-446
    DOI 10.1111/cpf.12247, PubMed 26039107
16. Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J (2015)
    Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females
    Scand J Public Health, 43 (3), 324-30
    DOI 10.1177/1403494815572206, PubMed 25740614
17. Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J (2015)
    Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas
    Anticancer Res, 35 (2), 1171-80
    PubMed 25667508
18. Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
    Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
    Mol Oncol, 9 (6), 1129-39
    DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404
19. Prasmickaite L, Berge G, Bettum IJ, Aamdal S, Hansson J, Bastholt L, Øijordsbakken M, Boye K, Mælandsmo GM (2015)
    Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial
    Cancer Immunol Immunother, 64 (6), 769-76
    DOI 10.1007/s00262-015-1686-4, PubMed 25832001

Publications 2014

1. Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, Bruland ØS (2014)
   Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma
   Acta Oncol, 54 (1), 25-33
   DOI 10.3109/0284186X.2014.923934, PubMed 24957555
2. Fogarty GB, Hong A, Jacobsen KD, Reisse CH, Shivalingam B, Burmeister B, Haydu LE, Paton E, Thompson JF (2014)
   Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
   BMC Res Notes, 7, 412
   DOI 10.1186/1756-0500-7-412, PubMed 24981506
3. Haugen MH, Boye K, Nesland JM, Pettersen SJ, Egeland EV, Tamhane T, Brix K, Maelandsmo GM, Flatmark K (2014)
   High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting
   Eur J Cancer, 51 (1), 9-17
   DOI 10.1016/j.ejca.2014.10.020, PubMed 25466510
4. Hong AM, Suo C, Valenzuela M, Haydu LE, Jacobsen KD, Reisse CH, Fogarty G (2014)
   Low incidence of melanoma brain metastasis in the hippocampus
   Radiother Oncol, 111 (1), 59-62
   DOI 10.1016/j.radonc.2014.01.012, PubMed 24560764
5. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
   B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
   BMC Cancer, 14, 602
   DOI 10.1186/1471-2407-14-602, PubMed 25139714
6. Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P (2014)
   Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
   Cancer, 120 (15), 2325-33
   DOI 10.1002/cncr.28669, PubMed 24737415
7. Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS (2014)
   Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
   Acta Oncol, 53 (9), 1180-7
   DOI 10.3109/0284186X.2014.899433, PubMed 24697744
8. Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S (2014)
   Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification
   Int J Oncol, 45 (5), 1829-36
   DOI 10.3892/ijo.2014.2605, PubMed 25176350
9. Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S (2014)
   Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma
   Oncol Rep, 32 (1), 40-4
   DOI 10.3892/or.2014.3180, PubMed 24839999
10. Repetto-Llamazares A, Abbas N, Bruland ØS, Dahle J, Larsen RH (2014)
    Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors
    Anticancer Res, 34 (7), 3263-9
    PubMed 24982330
11. Repetto-Llamazares AH, Larsen RH, Giusti AM, Riccardi E, Bruland ØS, Selbo PK, Dahle J (2014)
    177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice
    PLoS One, 9 (7), e103070
    DOI 10.1371/journal.pone.0103070, PubMed 25068508
12. Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C (2014)
    Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
    Lancet Oncol, 15 (7), 738-46
    DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273
13. Switlyk MD, Bruland ØS, Skjeldal S, Hald JK, Seierstad T, Zaikova O (2014)
    Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI
    J Bone Oncol, 3 (1), 5-9
    DOI 10.1016/j.jbo.2014.02.003, PubMed 26909292

Publications 2013

1. Abbas N, Heyerdahl H, Bruland ØS, Brevik EM, Dahle J (2013)
   Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts
   Curr Radiopharm, 6 (2), 78-86
   DOI 10.2174/18744710113069990017, PubMed 23551110
2. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD (2013)
   Incidence and mortality of second sarcomas - a population-based study
   Eur J Cancer, 49 (15), 3292-302
   DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025
3. Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS (2013)
   High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study
   Pediatr Blood Cancer, 61 (5), 840-5
   DOI 10.1002/pbc.24868, PubMed 24254749
4. Dahle J, Repetto-Llamazares AH, Mollatt CS, Melhus KB, Bruland OS, Kolstad A, Larsen RH (2013)
   Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphoma
   Anticancer Res, 33 (1), 85-95
   PubMed 23267131
5. Friedman R, Boye K, Flatmark K (2013)
   Molecular modelling and simulations in cancer research
   Biochim Biophys Acta, 1836 (1), 1-14
   DOI 10.1016/j.bbcan.2013.02.001, PubMed 23416097
6. Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA (2013)
   Malignant melanoma--diagnosis, treatment and follow-up in Norway
   Tidsskr Nor Laegeforen, 133 (20), 2154-9
   DOI 10.4045/tidsskr.12.1416, PubMed 24172628
7. Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland Ø, Dahle J (2013)
   Targeted alpha therapy with 227Th-trastuzumab of intraperitoneal ovarian cancer in nude mice
   Curr Radiopharm, 6 (2), 106-16
   DOI 10.2174/18744710113069990018, PubMed 23551111
8. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
   Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
   Neuro Oncol, 16 (2), 320-2
   DOI 10.1093/neuonc/not230, PubMed 24311631
9. Jebsen NL, Engellau J, Engström K, Bauer HC, Monge OR, Muren LP, Eide GE, Trovik CS, Bruland OS (2013)
   Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall
   Int J Radiat Oncol Biol Phys, 86 (5), 949-55
   DOI 10.1016/j.ijrobp.2013.04.015, PubMed 23725998
10. Lagunova Z, Porojnicu AC, Aksnes L, Holick MF, Iani V, Bruland OS, Moan J (2013)
    Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial
    Br J Dermatol, 169 (2), 434-40
    DOI 10.1111/bjd.12349, PubMed 23551243
11. Lia K, Bruland ØS, Randem HL, Aksnes LH, Poulsen JP, Taksdal I, Sundby Hall K (2013)
    Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma
    J Bone Oncol, 2 (4), 174-9
    DOI 10.1016/j.jbo.2013.09.002, PubMed 26909289
12. Mikalsen LT, Dhakal HP, Bruland ØS, Naume B, Borgen E, Nesland JM, Olsen DR (2013)
    The clinical impact of mean vessel size and solidity in breast carcinoma patients
    PLoS One, 8 (10), e75954
    DOI 10.1371/journal.pone.0075954, PubMed 24146798
13. Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG et al. (2013)
    Alpha emitter radium-223 and survival in metastatic prostate cancer
    N Engl J Med, 369 (3), 213-23
    DOI 10.1056/NEJMoa1213755, PubMed 23863050
14. Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T (2013)
    Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
    Acta Oncol, 53 (1), 143-8
    DOI 10.3109/0284186X.2013.798428, PubMed 23710697
15. Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
    Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
    Acta Oncol, 52 (4), 776-82
    DOI 10.3109/0284186X.2013.770920, PubMed 23480638
16. Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM (2013)
    Osteopontin is a prognostic biomarker in non-small cell lung cancer
    BMC Cancer, 13, 540
    DOI 10.1186/1471-2407-13-540, PubMed 24215488
17. Rusten E, Rødal J, Bruland Ø, Malinen E (2013)
    Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy
    Acta Oncol, 52 (7), 1378-83
    DOI 10.3109/0284186X.2013.813071, PubMed 23981046

Publications 2012

1. Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
   Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
   Nucl Med Commun, 33 (8), 838-47
   DOI 10.1097/MNM.0b013e328354df7c, PubMed 22643311
2. Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
   High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
   Br J Clin Pharmacol, 73 (1), 106-14
   DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700
3. Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D (2012)
   Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
   Int J Radiat Oncol Biol Phys, 84 (3), 572-80
   DOI 10.1016/j.ijrobp.2012.01.062, PubMed 22520481
4. Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
   B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
   Int J Cancer, 131 (11), 2528-36
   DOI 10.1002/ijc.27566, PubMed 22473715
5. Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2012)
   Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
   Neuro Oncol, 15 (2), 135-47
   DOI 10.1093/neuonc/nos287, PubMed 23161774
6. Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
   Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
   Melanoma Res, 22 (6), 460-5
   DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822
7. Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
   Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
   Sarcoma, 2012, 639038
   DOI 10.1155/2012/639038, PubMed 22518090
8. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS (2012)
   Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
   Clin Genitourin Cancer, 11 (1), 20-6
   DOI 10.1016/j.clgc.2012.07.002, PubMed 23021204
9. Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS (2012)
   A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
   Eur J Cancer, 48 (5), 678-86
   DOI 10.1016/j.ejca.2011.12.023, PubMed 22341993
10. Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K (2012)
    Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
    BMC Cancer, 12, 333
    DOI 10.1186/1471-2407-12-333, PubMed 22853000
11. Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
    Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
    Acta Oncol, 52 (6), 1160-7
    DOI 10.3109/0284186X.2012.728713, PubMed 23198721
12. Sartor O, Hoskin P, Bruland OS (2012)
    Targeted radio-nuclide therapy of skeletal metastases
    Cancer Treat Rev, 39 (1), 18-26
    DOI 10.1016/j.ctrv.2012.03.006, PubMed 22534284
13. Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
    Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
    BMC Cancer, 12, 505
    DOI 10.1186/1471-2407-12-505, PubMed 23121918
14. Schee K, Flatmark K, Holm R, Boye K, Paus E (2012)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients (vol 33, pg 73, 2012)
    Tumor Biol., 33 (4), 1263-1264
    DOI 10.1007/s13277-012-0407-2

Publications 2011

1. Abbas N, Heyerdahl H, Bruland OS, Borrebæk J, Nesland J, Dahle J (2011)
   Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab
   EJNMMI Res, 1 (1), 18
   DOI 10.1186/2191-219X-1-18, PubMed 22214432
2. Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T (2011)
   Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005)
   Cancer Epidemiol Biomarkers Prev, 20 (8), 1770-7
   DOI 10.1158/1055-9965.EPI-11-0136, PubMed 21724855
3. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ (2011)
   Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway
   Can J Vet Res, 75 (3), 209-15
   PubMed 22210997
4. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM (2011)
   Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis
   Int J Cancer, 129 (4), 780-90
   DOI 10.1002/ijc.25735, PubMed 20957651
5. Dahle J, Abbas N, Bruland ØS, Larsen RH (2011)
   Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates
   Curr Radiopharm, 4 (4), 321-8
   DOI 10.2174/1874471011104040321, PubMed 22202154
6. Mikalsen LT, Dhakal HP, Bruland OS, Nesland JM, Olsen DR (2011)
   Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections
   Anticancer Res, 31 (12), 4053-60
   PubMed 22199261
7. Revheim ME, Røe K, Bruland ØS, Bach-Gansmo T, Skretting A, Seierstad T (2011)
   Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
   Mol Imaging Biol, 13 (6), 1234-40
   DOI 10.1007/s11307-010-0464-0, PubMed 21161686
8. Sartor O, Bruland O (2011)
   Stromal targeted therapies in prostate and renal cancer: new concepts and knowledge
   Clin Genitourin Cancer, 9 (1), 1-2
   DOI 10.1016/j.clgc.2011.08.001, PubMed 21925102
9. Sartor O, Goeckeler W, Bruland O (2011)
   Stromal targeted therapy in bone metastatic prostate cancer: promise delivered
   Asian J Androl, 13 (6), 783-4
   DOI 10.1038/aja.2011.120, PubMed 21857688
10. Schee K, Flatmark K, Holm R, Boye K, Paus E (2011)
    Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
    Tumour Biol, 33 (1), 73-83
    DOI 10.1007/s13277-011-0247-5, PubMed 22006279
11. Smeland S, Bruland OS, Hjorth L, Brosjö O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Björk O, Alvegaard TA (2011)
    Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years
    Acta Orthop, 82 (2), 211-6
    DOI 10.3109/17453674.2011.566141, PubMed 21434784
12. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for girls and young women with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1429-32
    DOI 10.4045/tidsskr.11.0126, PubMed 21844944
13. Stensvold E, Magelssen H, Oskam IC (2011)
    Fertility-preserving measures for boys and young men with cancer
    Tidsskr Nor Laegeforen, 131 (15), 1433-5
    DOI 10.4045/tidsskr.11.0426, PubMed 21844945
14. Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
    Radiotherapy or surgery for spine metastases?
    Acta Orthop, 82 (3), 365-71
    DOI 10.3109/17453674.2011.566142, PubMed 21434789

Publications 2010

1. Brekke HR, Ribeiro FR, Kolberg M, Agesen TH, Lind GE, Eknaes M, Hall KS, Bjerkehagen B, van den Berg E, Teixeira MR, Mandahl N, Smeland S, Mertens F, Skotheim RI, Lothe RA (2010)
   Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
   J Clin Oncol, 28 (9), 1573-82
   DOI 10.1200/JCO.2009.24.8989, PubMed 20159821
2. Cicarma E, Juzeniene A, Porojnicu AC, Bruland ØS, Moan J (2010)
   Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007
   J Photochem Photobiol B, 101 (2), 174-8
   DOI 10.1016/j.jphotobiol.2010.04.002, PubMed 20430639
3. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
   CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
   Strahlenther Onkol, 186 (3), 163-8
   DOI 10.1007/s00066-010-2040-6, PubMed 20165821
4. Grotterød I, Maelandsmo GM, Boye K (2010)
   Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB
   BMC Cancer, 10, 241
   DOI 10.1186/1471-2407-10-241, PubMed 20507646
5. Jacobsen KD, Tausjø J, Hager B, Gundersen S (2010)
   [Treatment of metastatic malignant melanoma localized to an extremity]
   Tidsskr Nor Laegeforen, 130 (1), 21-4
   DOI 10.4045/tidsskr.09.0701, PubMed 20094118
6. Jebsen NL, Bruland ØS, Eriksson M, Engellau J, Turesson I, Folin A, Trovik CS, Hall KS (2010)
   Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall
   Int J Radiat Oncol Biol Phys, 81 (5), 1359-66
   DOI 10.1016/j.ijrobp.2010.07.037, PubMed 20933339
7. König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
   Multimodal treatment of osteogenic sarcoma of the jaw
   Skull Base, 20 (3), 207-12
   DOI 10.1055/s-0029-1246221, PubMed 21318040
8. Lagunova Z, Porojnicu AC, Grant WB, Bruland Ø, Moan JE (2010)
   Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?
   Mol Nutr Food Res, 54 (8), 1127-33
   DOI 10.1002/mnfr.200900512, PubMed 20512788
9. Moan J, Lagunova Z, Bruland O, Juzeniene A (2010)
   Seasonal variations of cancer incidence and prognosis
   Dermatoendocrinol, 2 (2), 55-7
   DOI 10.4161/derm.2.2.12664, PubMed 21547098
10. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T (2010)
    DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
    Acta Oncol, 50 (1), 148-50
    DOI 10.3109/0284186X.2010.516273, PubMed 21110775

Publications 2009

1. Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
   Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
   Prostate Cancer Prostatic Dis, 12 (3), 269-76
   DOI 10.1038/pcan.2009.8, PubMed 19290019
2. Brandal P, Bjerkehagen B, Bruland OS, Skjeldal S, Bogsrud TV, Hall KS (2009)
   Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience
   Acta Oncol, 48 (8), 1165-72
   DOI 10.3109/02841860903032809, PubMed 19863225
3. Brekke HR, Kolberg M, Skotheim RI, Hall KS, Bjerkehagen B, Risberg B, Domanski HA, Mandahl N, Liestøl K, Smeland S, Danielsen HE, Mertens F, Lothe RA (2009)
   Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
   Neuro Oncol, 11 (5), 514-28
   DOI 10.1215/15228517-2008-127, PubMed 19182148
4. Bruland ØS, Bauer H, Alvegaard T, Smeland S (2009)
   Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience
   Cancer Treat Res, 152, 309-18
   DOI 10.1007/978-1-4419-0284-9_16, PubMed 20213398
5. Bruland ØS, Høifødt H, Hall KS, Smeland S, Fodstad Ø (2009)
   Bone marrow micrometastases studied by an immunomagnetic isolation procedure in extremity localized non-metastatic osteosarcoma patients
   Cancer Treat Res, 152, 509-15
   DOI 10.1007/978-1-4419-0284-9_30, PubMed 20213412
6. Hall KS, Eriksson M, Bruland OS, Engellau J, Trovik CS (2009)
   Treatment of soft tissue sarcoma of the extremity and trunk wall The Scandinavian Sarcoma Group perspective
   Acta Orthop., 80 334, 52-59
7. Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS (2009)
   Small round cell sarcomas
   Semin Oncol, 36 (4), 338-46
   DOI 10.1053/j.seminoncol.2009.06.006, PubMed 19664494
8. Norum OJ, Bruland ØS, Gorunova L, Berg K (2009)
   Photochemical internalization of bleomycin before external-beam radiotherapy improves locoregional control in a human sarcoma model
   Int J Radiat Oncol Biol Phys, 75 (3), 878-85
   DOI 10.1016/j.ijrobp.2009.04.039, PubMed 19665318
9. Revheim ME, Seierstad T, Berner JM, Bruland OS, Røe K, Ohnstad HO, Bjerkehagen B, Bach-Gansmo T (2009)
   Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
   Anticancer Res, 29 (11), 4331-6
   PubMed 20032375
10. Sande TA, Ruenes R, Lund JA, Bruland OS, Hornslien K, Bremnes R, Kaasa S (2009)
    Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial
    Radiother Oncol, 91 (2), 261-6
    DOI 10.1016/j.radonc.2009.02.014, PubMed 19307034
11. Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S (2009)
    The role of radiotherapy in oseosarcoma
    Cancer Treat Res, 152, 147-64
    DOI 10.1007/978-1-4419-0284-9_7, PubMed 20213389
12. Smeland S, Bruland OS, Hjorth L, Brosjo O, Bjerkehagen B, Osterlundh G, Jakobson A, Hall KS, Monge OR, Bjork O, Alvegaard TA (2009)
    Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
    Acta Orthop., 80 334, 60-66
13. Smeland S, Wiebe T, Monge OR, Brosjo O, Bohling T, Hjorth L, Hall KS, Jakobson A, Alvegaard TA (2009)
    Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
    Acta Orthop., 80, 75-78
14. Søvik S, Skogmo HK, Andersen EK, Bruland ØS, Olsen DR, Malinen E (2009)
    DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis
    Radiother Oncol, 93 (3), 618-24
    DOI 10.1016/j.radonc.2009.08.012, PubMed 19747746

Publications 2008

1. Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
   Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
   Prostate, 68 (15), 1607-14
   DOI 10.1002/pros.20826, PubMed 18655095
2. Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
   Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
   Acta Oncol, 47 (8), 1475-82
   DOI 10.1080/02841860802047387, PubMed 18607853
3. Bruland OS, Jonasdottir TJ, Fisher DR, Larsen RH (2008)
   Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
   Curr. Radiopharm., 1 (3), 203-208
   DOI 10.2174/1874471010801030203
4. Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2008)
   Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
   J Clin Oncol, 27 (3), 334-43
   DOI 10.1200/JCO.2007.15.3130, PubMed 19075285
5. Dahle J, Bruland OS, Larsen RH (2008)
   Relative biologic effects of low-dose-rate alpha-emitting 227Th-rituximab and beta-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
   Int J Radiat Oncol Biol Phys, 72 (1), 186-92
   DOI 10.1016/j.ijrobp.2008.05.029, PubMed 18722269
6. Erikson A, Tufto I, Bjønnum AB, Bruland ØS, Davies Cde L (2008)
   The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules
   Anticancer Res, 28 (6A), 3557-66
   PubMed 19189635
7. Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegård T, Bruland OS (2008)
   Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study
   Int J Radiat Oncol Biol Phys, 71 (4), 1196-203
   DOI 10.1016/j.ijrobp.2007.11.023, PubMed 18207661
8. Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
   [Gonadal function after cancer treatment in adult men]
   Tidsskr Nor Laegeforen, 128 (4), 461-5
   PubMed 18274582
9. Porojnicu AC, Bruland OS, Aksnes L, Grant WB, Moan J (2008)
   Sun beds and cod liver oil as vitamin D sources
   J Photochem Photobiol B, 91 (2-3), 125-31
   DOI 10.1016/j.jphotobiol.2008.02.007, PubMed 18417354
10. Søvik A, Kippenes Skogmo H, Bruland ØS, Rune Olsen D, Malinen E (2008)
    DCEMRI monitoring of canine tumors during fractionated radiotherapy
    Acta Oncol, 47 (7), 1249-56
    DOI 10.1080/02841860802244166, PubMed 18618342
11. Vågane R, Bruland ØS, Fosså SD, Olsen DR (2008)
    Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
    Acta Oncol, 47 (2), 248-54
    DOI 10.1080/02841860701630267, PubMed 18210300

Publications 2007

1. Aksnes LH, Bruland ØS (2007)
   Some musculo-skeletal sequelae in cancer survivors
   Acta Oncol, 46 (4), 490-6
   DOI 10.1080/02841860701218642, PubMed 17497316
2. Aksnes LH, Hall KS, Jebsen N, Fosså SD, Dahl AA (2007)
   Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
   Support Care Cancer, 15 (9), 1087-96
   DOI 10.1007/s00520-007-0227-x, PubMed 17347843
3. Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
   Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
   Int J Cancer, 120 (8), 1603-9
   DOI 10.1002/ijc.22488, PubMed 17230512
4. Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
   10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
   Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
   DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896
5. Dahle J, Borrebaek J, Jonasdottir TJ, Hjelmerud AK, Melhus KB, Bruland ØS, Press OW, Larsen RH (2007)
   Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate
   Blood, 110 (6), 2049-56
   DOI 10.1182/blood-2007-01-066803, PubMed 17536011
6. Larsen RH, Borrebaek J, Dahle J, Melhus KB, Krogh C, Valan MH, Bruland OS (2007)
   Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
   Cancer Biother Radiopharm, 22 (3), 431-7
   DOI 10.1089/cbr.2006.321, PubMed 17651051
7. Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, Yachnin J, Garkavij M, Strang P, Harmenberg J, Bolstad B, Bruland OS (2007)
   Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
   Lancet Oncol, 8 (7), 587-94
   DOI 10.1016/S1470-2045(07)70147-X, PubMed 17544845
8. Olsen DR, Bruland OS, Frykholm G, Norderhaug IN (2007)
   Proton therapy - a systematic review of clinical effectiveness
   Radiother Oncol, 83 (2), 123-32
   DOI 10.1016/j.radonc.2007.03.001, PubMed 17499374
9. Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J (2007)
   Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
   Lung Cancer, 55 (3), 263-70
   DOI 10.1016/j.lungcan.2006.11.013, PubMed 17207891
10. Søvik A, Malinen E, Skogmo HK, Bentzen SM, Bruland OS, Olsen DR (2007)
    Radiotherapy adapted to spatial and temporal variability in tumor hypoxia
    Int J Radiat Oncol Biol Phys, 68 (5), 1496-504
    DOI 10.1016/j.ijrobp.2007.04.027, PubMed 17674980

Publications 2006

1. Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, Winderen M, Bruland OS, Saeter G (2006)
   Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience
   Acta Oncol, 45 (1), 38-46
   DOI 10.1080/02841860500466624, PubMed 16464794
2. Bruland ØS (2006)
   [Jumping after the Swedes]
   Tidsskr Nor Laegeforen, 126 (5), 637
   PubMed 16505887
3. Bruland ØS, Nilsson S, Fisher DR, Larsen RH (2006)
   High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
   Clin Cancer Res, 12 (20 Pt 2), 6250s-6257s
   DOI 10.1158/1078-0432.CCR-06-0841, PubMed 17062709
4. Dahle J, Borrebaek J, Melhus KB, Bruland OS, Salberg G, Olsen DR, Larsen RH (2006)
   Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapy
   Nucl Med Biol, 33 (2), 271-9
   DOI 10.1016/j.nucmedbio.2005.12.004, PubMed 16546683
5. Jacobsen KD, Fosså SD, Aamdal S (2006)
   [Malignant melanoma--diagnosis and treatment]
   Tidsskr Nor Laegeforen, 126 (23), 3094-7
   PubMed 17160112
6. Jonasdottir TJ, Fisher DR, Borrebaek J, Bruland OS, Larsen RH (2006)
   First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent
   Anticancer Res, 26 (4B), 2841-8
   PubMed 16886603
7. Larsen RH, Saxtorph H, Skydsgaard M, Borrebaek J, Jonasdottir TJ, Bruland OS, Klastrup S, Harling R, Ramdahl T (2006)
   Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology
   In Vivo, 20 (3), 325-31
   PubMed 16724665
8. Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L (2006)
   Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference
   Clin Cancer Res, 12 (20 Pt 2), 6209s-6212s
   DOI 10.1158/1078-0432.CCR-06-1213, PubMed 17062702
9. Malinen E, Søvik A, Hristov D, Bruland ØS, Olsen DR (2006)
   Adapting radiotherapy to hypoxic tumours
   Phys Med Biol, 51 (19), 4903-21
   DOI 10.1088/0031-9155/51/19/012, PubMed 16985278
10. Søvik A, Malinen E, Bruland ØS, Bentzen SM, Olsen DR (2006)
    Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study
    Phys Med Biol, 52 (2), 499-513
    DOI 10.1088/0031-9155/52/2/013, PubMed 17202629

Publications 2005

1. Brustugun OT, Reed W, Poulsen JP, Bruland OS (2005)
   Primary osteosarcoma of the breast
   Acta Oncol, 44 (7), 767-70
   DOI 10.1080/02841860500254897, PubMed 16227171
2. Dale E, Hellebust TP, Bruland ØS, Olsen DR (2005)
   Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers
   Br J Radiol, 78 (930), 528-32
   DOI 10.1259/bjr/82990907, PubMed 15900058
3. Eikenes L, Tari M, Tufto I, Bruland OS, de Lange Davies C (2005)
   Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts
   Br J Cancer, 93 (1), 81-8
   DOI 10.1038/sj.bjc.6602626, PubMed 15942637
4. Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
   Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
   J Natl Cancer Inst Monogr (34), 77-82
   DOI 10.1093/jncimonographs/lgi019, PubMed 15784830
5. Henriksen G, Bruland OS, Larsen RH (2005)
   Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies
   Anticancer Res, 25 (1A), 9-15
   PubMed 15816513
6. Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
   Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
   Eur Urol, 48 (5), 779-85
   DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629
7. Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
   First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
   Clin Cancer Res, 11 (12), 4451-9
   DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630
8. Norum J, Bruland ØS, Spanne O, Bergmo T, Green T, Olsen DR, Olsen JH, Sjåeng EE, Burkow T (2005)
   Telemedicine in radiotherapy: a study exploring remote treatment planning, supervision and economics
   J Telemed Telecare, 11 (5), 245-50
   DOI 10.1258/1357633054471858, PubMed 16035967
9. Ohm-Laursen L, Schjebel L, Jacobsen K, Permin H, Svejgaard A, Barington T (2005)
   Normal ICOS, ICOSL and AID alleles in Danish patients with common variable immunodeficiency
   Scand J Immunol, 61 (6), 566-74
   DOI 10.1111/j.1365-3083.2005.001603.x, PubMed 15963052
10. Onda M, Bruland ØS, Pastan I (2005)
    TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma
    Clin Orthop Relat Res (430), 142-8
    DOI 10.1097/01.blo.0000137544.30200.b6, PubMed 15662316

Publications 2004

1. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O (2004)
   Human osteosarcoma xenografts and their sensitivity to chemotherapy
   Pathol Oncol Res, 10 (3), 133-41
   DOI 10.1007/BF03033741, PubMed 15448748
2. Eikenes L, Bruland ØS, Brekken C, Davies Cde L (2004)
   Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts
   Cancer Res, 64 (14), 4768-73
   DOI 10.1158/0008-5472.CAN-03-1472, PubMed 15256445
3. Engellau J, Anderson H, Rydholm A, Bauer HC, Hall KS, Gustafson P, Akerman M, Meis-Kindblom J, Alvegård TA, Nilbert M, Scandinavian Sarcoma Group (2004)
   Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
   Cancer, 100 (10), 2233-9
   DOI 10.1002/cncr.20254, PubMed 15139069
4. Fosså SD, Magelssen H (2004)
   Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
   Ann Oncol, 15 Suppl 4, iv259-65
   DOI 10.1093/annonc/mdh936, PubMed 15477318
5. Henriksen G, Bruland OS, Larsen RH (2004)
   Thorium and actinium polyphosphonate compounds as bone-seeking alpha particle-emitting agents
   Anticancer Res, 24 (1), 101-5
   PubMed 15015582
6. Henriksen G, Schoultz BW, Michaelsen TE, Bruland ØS, Larsen RH (2004)
   Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides
   Nucl Med Biol, 31 (4), 441-9
   DOI 10.1016/j.nucmedbio.2003.11.004, PubMed 15093814
7. Mahabir E, Jacobsen K, Brielmeier M, Peters D, Needham J, Schmidt J (2004)
   Mouse antibody production test: can we do without it?
   J Virol Methods, 120 (2), 239-45
   DOI 10.1016/j.jviromet.2004.05.006, PubMed 15288967
8. Mikkelsen IM, Løkke C, Flagstad T, Bruland ØS (2004)
   Interferon-γ Sensitises Human Osteosarcoma Cells to Trail-mediated Apoptosis
   Cancer Genomics Proteomics, 1 (2), 95-104
   PubMed 31394674
9. Schoemaker NE, Kuppens IE, Moiseyenko V, Glimelius B, Kjaer M, Starkhammer H, Richel DJ, Smaaland R, Bertelsen K, Poulsen JP, Voznyi E, Norum J, Fennelly D, Tveit KM, Garin A, Gruia G, Mourier A, Sibaud D, Lefebvre P, Beijnen JH, Schellens JH, ten Bokkel Huinink WW (2004)
   A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
   Br J Cancer, 91 (8), 1434-41
   DOI 10.1038/sj.bjc.6602172, PubMed 15381932

Publications 2003

1. Dale E, Hellebust TP, Bruland ØS, Olsen DR (2003)
   Comparative analyses of the dynamic properties of the rectum studied by cryo-sections of human cadavers and pelvic CT scans of patients
   Br J Radiol, 76 (902), 104-8
   DOI 10.1259/bjr/75640835, PubMed 12642278
2. Dueland S, Guren MG, Olsen DR, Poulsen JP, Magne Tveit K (2003)
   Radiation therapy induced changes in male sex hormone levels in rectal cancer patients
   Radiother Oncol, 68 (3), 249-53
   DOI 10.1016/s0167-8140(03)00120-8, PubMed 13129632
3. Fuxe K, Agnati LF, Jacobsen K, Hillion J, Canals M, Torvinen M, Tinner-Staines B, Staines W, Rosin D, Terasmaa A, Popoli P, Leo G, Vergoni V, Lluis C, Ciruela F, Franco R, Ferré S (2003)
   Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease
   Neurology, 61 (11 Suppl 6), S19-23
   DOI 10.1212/01.wnl.0000095206.44418.5c, PubMed 14663004
4. Guren MG, Dueland S, Skovlund E, Fosså SD, Poulsen JP, Tveit KM (2003)
   Quality of life during radiotherapy for rectal cancer
   Eur J Cancer, 39 (5), 587-94
   DOI 10.1016/s0959-8049(02)00741-4, PubMed 12628837
5. Henriksen G, Fisher DR, Roeske JC, Bruland ØS, Larsen RH (2003)
   Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice
   J Nucl Med, 44 (2), 252-9
   PubMed 12571218
6. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
   Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
   Anticancer Res, 23 (3B), 2201-16
   PubMed 12894494

Publications 2002

1. Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS (2002)
   High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
   J Clin Oncol, 20 (1), 189-96
   DOI 10.1200/JCO.2002.20.1.189, PubMed 11773169
2. Aurlien E, Kvinnsland Y, Larsen RH, Bruland ØS (2002)
   Radiation doses to non-Hodgkin's lymphoma cells and normal bone marrow exposed in vitro. Comparison of an alpha-emitting radioimmunoconjugate and external gamma-irradiation
   Int J Radiat Biol, 78 (2), 133-42
   DOI 10.1080/09553000110094788, PubMed 11779363
3. Ghadimi BM, Horstmann O, Jacobsen K, Feth J, Becker H (2002)
   Delay of diagnosis in pancreatic cancer due to suspected symptomatic cholelithiasis
   Scand J Gastroenterol, 37 (12), 1437-9
   DOI 10.1080/003655202762671323, PubMed 12523594
4. Henriksen G, Breistøl K, Bruland ØS, Fodstad Ø, Larsen RH (2002)
   Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model
   Cancer Res, 62 (11), 3120-5
   PubMed 12036923
5. Jacobsen K, Zhang XN, Marzullo K (2002)
   Group membership and wide-area master-worker computations
   INT CON DISTR COMP S, 570-579
6. Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
   Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
   Eur Urol, 42 (3), 229-38; discussion 237-8
   DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507
7. Jakobsen A, Berglund A, Glimelius B, Frödin JE, Hansen F, Kjaer M, Madsen EL, Sandberg E, Poulsen JP, Carlsson G, Gustavsson B, Nordic Gastrointestinal Tumour Therapy Group, Norway, Sweden and Denmark (2002)
   Dose-effect relationship of bolus 5-fluorouracil in the treatment of advanced colorectal cancer
   Acta Oncol, 41 (6), 525-31
   DOI 10.1080/02841860214959, PubMed 12546525
8. Johansen D, Lauvset KJ, van Renesse R, Schneider FB, Sudmann NP, Jacobsen K (2002)
   A TACOMA retrospective
   Softw.-Pract. Exp., 32 (6), 605-619
   DOI 10.1002/spe.451
9. Kvinnsland Y, Bruland O, Moe L, Skretting A (2002)
   A method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of 89SrCl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma
   Eur J Nucl Med Mol Imaging, 29 (2), 191-7
   DOI 10.1007/s00259-001-0693-1, PubMed 11926381
10. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
11. Saeter G, Hall KS, Bruland ØS, Solheim ØP, Høie J, Follerås G, Helgerud P, Stenwig AE, Bjerkehagen B, Talle K, Taksdal I, Winderen M (2002)
    [Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]
    Tidsskr Nor Laegeforen, 122 (21), 2089-94
    PubMed 12555642
12. Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE (2002)
    Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer
    Eur J Surg, 168 (1), 42-8
    DOI 10.1080/110241502317307562, PubMed 12022371
13. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE (2002)
    Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study
    Radiother Oncol, 62 (2), 207-13
    DOI 10.1016/s0167-8140(01)00486-8, PubMed 11937248

Publications 2001

1. Jacobsen KD, Theodorsen L, Fossa SD (2001)
   Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
   J Urol, 165 (1), 93-6
   DOI 10.1097/00005392-200101000-00023, PubMed 11125372
2. Kvinnsland Y, Skretting A, Bruland OS (2001)
   Radionuclide therapy with bone-seeking compounds: Monte Carlo calculations of dose-volume histograms for bone marrow in trabecular bone
   Phys Med Biol, 46 (4), 1149-61
   DOI 10.1088/0031-9155/46/4/317, PubMed 11324957
3. Lauvset KJ, Jacobsen K, Johansen D, Marzullo K (2001)
   Position summary: Separating mobility from mobile agents
   EIGHTH WORKSHOP ON HOT TOPICS IN OPERATING SYSTEMS, PROCEEDINGS, 173
   DOI 10.1109/HOTOS.2001.990089
4. Onda M, Olafsen T, Tsutsumi Y, Bruland OS, Pastan I (2001)
   Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin A
   J Immunother, 24 (2), 144-50
   DOI 10.1097/00002371-200103000-00009, PubMed 11265772

Publications 2000

1. Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR, Bruland OS (2000)
   Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry
   Int J Radiat Biol, 76 (8), 1129-41
   DOI 10.1080/09553000050111604, PubMed 10947126
2. Aurlien E, Larsen RH, Kvalheim G, Bruland OS (2000)
   Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells
   Br J Cancer, 83 (10), 1375-9
   DOI 10.1054/bjoc.2000.1453, PubMed 11044364
3. Braendengen M, Bruland OS, Olsen DR (2000)
   [Radiotherapy of skeletal metastases]
   Tidsskr Nor Laegeforen, 120 (16), 1870-4
   PubMed 10925615
4. Brekken C, Bruland ØS, de Lange Davies C (2000)
   Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase
   Anticancer Res, 20 (5B), 3503-12
   PubMed 11131654
5. Brekken C, Hjelstuen MH, Bruland ØS, de Lange Davies C (2000)
   Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts
   Anticancer Res, 20 (5B), 3513-9
   PubMed 11131655
6. Jacobsen K (2000)
   "Fast tracking" drug approvals: is consumer safety being compromised?
   QRC Advis, 16 (8), 5-9
   PubMed 10977137
7. Jacobsen KD, Fosså SD (2000)
   Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle
   Eur Urol, 38 (6), 725-6;discussion 727
   DOI 10.1159/000020369, PubMed 11111191
8. Pihl A, Bruland OS (2000)
   Oral presentations in science and medicine. An art in decline?
   Anticancer Res, 20 (5A), 2795-9
   PubMed 11062686
9. Wiig JN, Poulsen JP, Tveit KM, Olsen DR, Giercksky KE (2000)
   Intra-operative irradiation (IORT) for primary advanced and recurrent rectal cancer. a need for randomised studies
   Eur J Cancer, 36 (7), 868-74
   DOI 10.1016/s0959-8049(00)00015-0, PubMed 10785591

Publications 1999

1. Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD (1999)
   Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
   Br J Cancer, 80 (1-2), 249-55
   DOI 10.1038/sj.bjc.6690347, PubMed 10390004
2. Jemtland R, Rian E, Olstad OK, Haug E, Bruland OS, Bucht E, Gautvik KM (1999)
   Two human osteoblast-like osteosarcoma cell lines show distinct expression and differential regulation of parathyroid hormone-related protein
   J Bone Miner Res, 14 (6), 904-14
   DOI 10.1359/jbmr.1999.14.6.904, PubMed 10352098
3. Johansen D, Marzullo K, Schneider FB, Jacobsen K, Zagorodnov D (1999)
   NAP: Practical fault-tolerance for itinerant computations
   INT CON DISTR COMP S, 180-189
   DOI 10.1109/ICDCS.1999.776519
4. Larsen RH, Murud KM, Akabani G, Hoff P, Bruland OS, Zalutsky MR (1999)
   211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation
   J Nucl Med, 40 (7), 1197-203
   PubMed 10405142
5. Murud KM, Larsen RH, Bruland OS, Hoff P (1999)
   Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of 211At and 125I-labeled amidobisphosphonates in mice
   Nucl Med Biol, 26 (7), 791-4
   DOI 10.1016/s0969-8051(99)00047-5, PubMed 10628558
6. Norum LF, Poulsen JP, Ruud TE, Giercksky KE, Røkke O (1999)
   [Abdominal metastases from signet cell carcinoma of the appendix vermiformis]
   Tidsskr Nor Laegeforen, 119 (3), 371-2
   PubMed 10074833
7. Olafsen T, Munthe Lund CK, Bruland OS, Sandlie I, Michaelsen TE (1999)
   Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
   Cancer Immunol Immunother, 48 (7), 411-8
   DOI 10.1007/s002620050594, PubMed 10501855
8. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O (1999)
   Expression of a novel factor in human breast cancer cells with metastatic potential
   Cancer Res, 59 (18), 4675-80
   PubMed 10493524
9. Tanum G, Bruland OS, Hjelle D, Reitan JB (1999)
   [Patient treatment in radiation accidents]
   Tidsskr Nor Laegeforen, 119 (10), 1446-50
   PubMed 10354753
10. Aas M, Moe L, Gamlem H, Skretting A, Ottesen N, Bruland OS (1999)
    Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP)
    Clin Cancer Res, 5 (10 Suppl), 3148s-3152s
    PubMed 10541356

Publications 1998

1. Gustafsson LL, Schildt B, Jacobsen K (1998)
   Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden. 1982
   Br J Anaesth, 81 (1), 86-93; discussion 85
   DOI 10.1093/bja/81.1.86, PubMed 9771276
2. Hassfjell SP, Skretting A, Bruland OS, Hoff P (1998)
   Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals
   Nucl Med Commun, 19 (3), 207-17
   DOI 10.1097/00006231-199803000-00004, PubMed 9625495
3. Helle SI, Geisler J, Poulsen JP, Hestdal K, Meadows K, Collins W, Tveit KM, Holly JM, Lønning PE (1998)
   Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study
   Br J Cancer, 78 (1), 14-20
   DOI 10.1038/bjc.1998.435, PubMed 9662244
4. Larsen RH, Bruland OS (1998)
   Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay
   Br J Cancer, 77 (7), 1115-22
   DOI 10.1038/bjc.1998.185, PubMed 9569048
5. Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simões M, Nesland JM (1998)
   Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
   Anal Cell Pathol, 16 (1), 45-62
   DOI 10.1155/1998/545906, PubMed 9584899
6. Olafsen T, Rasmussen IB, Norderhaug L, Bruland OS, Sandlie I (1998)
   IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells
   Immunotechnology, 4 (2), 141-53
   DOI 10.1016/s1380-2933(98)00014-1, PubMed 9853955
7. Olsen DR, Bruland OS (1998)
   Radiotherapy in Scandinavia
   Acta Oncol, 37 (6), 553-60
   DOI 10.1080/028418698430250, PubMed 9860313

Publications 1997

1. Bruland OS, Pihl A (1997)
   On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy
   Eur J Cancer, 33 (11), 1725-31
   DOI 10.1016/s0959-8049(97)00252-9, PubMed 9470825
2. Ekstrøm PO, Giercksky KE, Andersen A, Bruland OS, Slørdal L (1997)
   Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis
   Life Sci, 61 (19), PL275-80
   DOI 10.1016/s0024-3205(97)00839-4, PubMed 9364204
3. Hassfjell SP, Bruland OS, Hoff P (1997)
   212Bi-DOTMP: an alpha particle emitting bone-seeking agent for targeted radiotherapy
   Nucl Med Biol, 24 (3), 231-7
   DOI 10.1016/s0969-8051(97)00059-0, PubMed 9228657
4. Jacobsen K, Brun LO, Kirkendall L (1997)
   Morphological and physiological differences between resistant and susceptible strains of Hypothenemus hampei
   SEVENTEENTH INTERNATIONAL SCIENTIFIC COLLOQUIUM ON COFFEE, NAIROBI, JULY 20-25, 1997, 810-814
5. Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
   External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
   Int J Radiat Oncol Biol Phys, 38 (1), 95-102
   DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009
6. Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
   A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
   Pathol Res Pract, 193 (7), 471-8
   DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752
7. Lopes JM, Bruland OS, Bjerkehagen B, Silva MC, Holm R, Pettersen EO, Solheim OP, Sobrinho-Simões M, Nesland JM (1997)
   Synovial sarcoma: immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance
   Pathol Res Pract, 193 (1), 21-36
   DOI 10.1016/s0344-0338(97)80090-8, PubMed 9112270
8. Stueflotten S, Steen E, Kristiansen A, Jacobsen K (1997)
   Smoke emission testing of cables - How reliable are the results?
   COMMUNICATIONS CABLING - EC '97, 368-374
9. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
   Combined modality treatment including IORT in locally advanced and recurrent rectal cancer: results from a prospective Norwegian study
   Front Radiat Ther Oncol, 31, 221-3
   DOI 10.1159/000061129, PubMed 9263827
10. Tveit KM, Wiig JN, Olsen DR, Storaas A, Poulsen JP, Giercksky KE (1997)
    Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer
    Radiother Oncol, 44 (3), 277-82
    DOI 10.1016/s0167-8140(97)00070-4, PubMed 9380828

Publications 1996

1. Bruland OS, Skretting A, Solheim OP, Aas M (1996)
   Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach
   Acta Oncol, 35 (3), 381-4
   DOI 10.3109/02841869609101655, PubMed 8679270
2. Gordeladze JO, Lund HW, Jablonski G, Bruland OS (1996)
   Diverse expression of G-proteins in human sarcoma cell lines with different osteogenic potential: evidence for the involvement of Gi2 in cell proliferation
   J Cell Biochem, 60 (1), 95-106
   DOI 10.1002/(SICI)1097-4644(19960101)60:1%3C95::AID-JCB12%3E3.0.CO;2-J, PubMed 8825419
3. Jacobsen K (1996)
   Factors influencing the policy responses of host governments to mass refugee influxes
   Int Migr Rev, 30 (3), 655-78
   PubMed 12292015
4. Moe L, Boysen M, Aas M, Lønaas L, Gamlem H, Bruland OS (1996)
   Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma
   J Small Anim Pract, 37 (5), 241-6
   DOI 10.1111/j.1748-5827.1996.tb01782.x, PubMed 8736231
5. Olafsen T, Bruland OS, Zalutsky MR, Sandlie I (1996)
   Abundant tyrosine residues in the antigen binding site in anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: Application to radiolabeling
   Acta Oncol, 35 (3), 297-301
   DOI 10.3109/02841869609101644, PubMed 8679259
6. Saeter G, Bruland OS, Follerås G, Boysen M, Høie J (1996)
   Extremity and non-extremity high-grade osteosarcoma -- the Norwegian Radium Hospital experience during the modern chemotherapy era
   Acta Oncol, 35 Suppl 8, 129-34
   DOI 10.3109/02841869609098531, PubMed 9073059

Publications 1995

1. Brune H, Bromann K, Röder H, Kern K, Jacobsen J, Stoltze P, Jacobsen K, Norskov J (1995)
   Effect of strain on surface diffusion and nucleation
   Phys Rev B Condens Matter, 52 (20), 14380-14383
   DOI 10.1103/physrevb.52.r14380, PubMed 9980764
2. Larsen RH, Hoff P, Vergote IB, Bruland OS, Aas M, De Vos L, Nustad K (1995)
   Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
   Gynecol Oncol, 57 (1), 9-15
   DOI 10.1006/gyno.1995.1093, PubMed 7705707
3. Olafsen T, Bruland OS, Zalutsky MR, Sandlie I (1995)
   Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling
   Nucl Med Biol, 22 (6), 765-71
   DOI 10.1016/0969-8051(95)00014-o, PubMed 8535337
4. Skjeldal OH, von Tetzchner S, Jacobsen K, Smith L, Heiberg A (1995)
   Rett syndrome--distribution of phenotypes with special attention to the preserved speech variant
   Neuropediatrics, 26 (2), 87
   DOI 10.1055/s-2007-979732, PubMed 7566462

Publications 1994

1. Haerslev T, Jacobsen K, Nedergaard L, Zedeler K (1994)
   Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases
   Pathol Res Pract, 190 (7), 675-81
   DOI 10.1016/S0344-0338(11)80746-6, PubMed 7808966
2. Jacobsen K (1994)
   Deciding on injection sites
   MCN Am J Matern Child Nurs, 19 (4), 200
   DOI 10.1097/00005721-199407000-00006, PubMed 7934697
3. Jacobsen K (1994)
   [Neck pain, for the last time]
   Ugeskr Laeger, 156 (40), 5879-80
   PubMed 7985287
4. Jacobsen K (1994)
   [Daily clinical documentation]
   Ugeskr Laeger, 156 (22), 3333-4
   PubMed 8066857
5. Jacobsen K (1994)
   [Pain and the cervical vertebrae]
   Ugeskr Laeger, 156 (30), 4367
   PubMed 8066942
6. Jacobsen KD, Follerås G, Fosså SD (1994)
   Metastases from renal cell carcinoma to the humerus or the shoulder girdle
   Br J Urol, 73 (2), 124-8
   DOI 10.1111/j.1464-410x.1994.tb07478.x, PubMed 8131012
7. Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK (1994)
   Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays
   Radiat Res, 139 (2), 178-84
   DOI 10.2307/3578662, PubMed 8052693
8. Larsen RH, Bruland OS, Hoff P, Alstad J, Rofstad EK (1994)
   Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody
   Br J Cancer, 69 (6), 1000-5
   DOI 10.1038/bjc.1994.196, PubMed 8198960
9. Osmond DG, Rico-Vargas S, Valenzona H, Fauteux L, Liu L, Janani R, Lu L, Jacobsen K (1994)
   Apoptosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow
   Immunol Rev, 142, 209-30
   DOI 10.1111/j.1600-065x.1994.tb00891.x, PubMed 7698795
10. Page RL, Garg PK, Garg S, Archer GE, Bruland OS, Zalutsky MR (1994)
    PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment
    J Nucl Med, 35 (9), 1506-13
    PubMed 8071702
11. Petersen IS, Jepsen OB, Hartmann-Andersen JF, Toftegaard M, Haumann P, Knudsen KK, Jacobsen K, Hasselstrøm L, Engelsen J, Lauritsen HK (1994)
    [Pneumonia among patients admitted to intensive care units. An epidemiological multicenter study of APACHE II score, incidence and course]
    Ugeskr Laeger, 156 (36), 5126-30
    PubMed 7941054

Publications 1993

1. Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
   p53 abnormalities in different subtypes of human sarcomas
   Cancer Res, 53 (3), 468-71
   PubMed 8425179
2. Christensen PA, Rotne M, Vedelsdal R, Jensen RH, Jacobsen K, Husted C (1993)
   Electroacupuncture in anaesthesia for hysterectomy
   Br J Anaesth, 71 (6), 835-8
   DOI 10.1093/bja/71.6.835, PubMed 8280549
3. Jacobsen K (1993)
   [MMR-vaccinations and prevention of fatal cases]
   Ugeskr Laeger, 155 (37), 2908
   PubMed 8259621
4. Sidman CL, Shaffer DJ, Jacobsen K, Vargas SR, Osmond DG (1993)
   Cell populations during tumorigenesis in Eu-myc transgenic mice
   Leukemia, 7 (6), 887-95
   PubMed 8501983

Publications 1992

1. Bangsbo J, Jacobsen K, Nordberg N, Christensen NJ, Graham T (1992)
   Acute and habitual caffeine ingestion and metabolic responses to steady-state exercise
   J Appl Physiol (1985), 72 (4), 1297-303
   DOI 10.1152/jappl.1992.72.4.1297, PubMed 1592718
2. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
   Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
   Cancer Res, 52 (21), 6088-91
   PubMed 1356624
3. Fosså SD, Poulsen JP, Aaserud A (1992)
   Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer
   Lancet, 340 (8834-8835), 1544
   DOI 10.1016/0140-6736(92)92794-g, PubMed 1281904
4. Haines DM, Bruland OS, Matte G, Wilkinson AA, Meric SM, Fowler JD (1992)
   Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1
   Anticancer Res, 12 (6B), 2151-7
   PubMed 1295462
5. Hansen TW, Poulsen JP, Bratlid D (1992)
   The effects of hypoxanthine, xanthine oxidase and hyperoxia on the accumulation of bilirubin and albumin in young rat brain
   Early Hum Dev, 30 (2), 171-7
   DOI 10.1016/0378-3782(92)90144-6, PubMed 1493769
6. Osmond DG, Jacobsen K, Fauteux L, Valenzona H, Rico-Vargas S (1992)
   Multiple steps in the regulation and dysregulation of B-cell precursors in the bone marrow: c-myc expression, in vivo effects of interleukins 1 and 7, and stromal cell interactions
   Curr Top Microbiol Immunol, 182, 45-54
   DOI 10.1007/978-3-642-77633-5_6, PubMed 1490384
7. Osmond DG, Kim N, Manoukian R, Phillips RA, Rico-Vargas SA, Jacobsen K (1992)
   Dynamics and localization of early B-lymphocyte precursor cells (pro-B cells) in the bone marrow of scid mice
   Blood, 79 (7), 1695-703
   PubMed 1373084

Publications 1990

1. Agner E, Christensen TE, Jacobsen K, Baastrup A, Mahnfeldt MS, Jensen SE (1990)
   [Formalized dietary advice in hypercholesterolemia. Results in 110 men diagnosed by selective screening in general practice]
   Ugeskr Laeger, 152 (45), 3344-6
   PubMed 2238224
2. Agner E, Christensen TE, Mahnfeldt MS, Baastrup A, Jacobsen K, Jensen SE (1990)
   [Selective screening for hypercholesterolemia. Results from a screening model in general practice]
   Ugeskr Laeger, 152 (45), 3340-4
   PubMed 2238223
3. Agner E, Jacobsen K, Mahnfeldt MS, Jensen SE, Baastrup A, Stene GM, Bech J, Kjaer A (1990)
   [Screening for cardiovascular risk factors in a large workplace]
   Ugeskr Laeger, 152 (45), 3348-51
   PubMed 2238226
4. Christensen TE, Agner E, Jensen SE, Jacobsen K, Mahnfeldt MS, Baastrup A (1990)
   [Measurement of blood cholesterol, decentralized, using a Reflotron, or centralized in a laboratory. A comparison]
   Ugeskr Laeger, 152 (45), 3346-8
   PubMed 2238225
5. Fjeld JG, Bruland OS, Benestad HB, Schjerven L, Stigbrand T, Nustad K (1990)
   Radioimmunotargeting of human tumour cells in immunocompetent animals
   Br J Cancer, 62 (4), 573-8
   DOI 10.1038/bjc.1990.332, PubMed 2223574
6. Lund B, Jacobsen K, Rasch L, Jensen F, Olesen K, Feldt-Rasmussen K (1990)
   Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinoma
   Gynecol Oncol, 37 (2), 279-83
   DOI 10.1016/0090-8258(90)90348-o, PubMed 2188880
7. Ottesen B, Jacobsen K, Andresen A, Ulrichsen H, Thomsen HK, Larsson LI (1990)
   Opioid-like immunoreactants in human cervical cancer
   Gynecol Oncol, 36 (2), 250-5
   DOI 10.1016/0090-8258(90)90183-l, PubMed 2298415

Publications 1989

1. Haines DM, Bruland OS (1989)
   Immunohistochemical detection of osteosarcoma-associated antigen in canine osteosarcoma
   Anticancer Res, 9 (4), 903-7
   PubMed 2684000
2. Iversen BF, Stürup J, Jacobsen K, Andersen J (1989)
   Implications of muscular defense in testing for the anterior drawer sign in the knee. A stress radiographic investigation
   Am J Sports Med, 17 (3), 409-13
   DOI 10.1177/036354658901700316, PubMed 2729492
3. Jacobsen K, Mathiassen B, Iversen AD (1989)
   [Life-threatening hypokalemia during a weight reducing regimen in a woman with hypertension treated with diuretics]
   Ugeskr Laeger, 151 (9), 574
   PubMed 2922872
4. Lyndrup P, Iversen BF, Andersen J, Jacobsen K (1989)
   Total condylar knee arthroplasty. Implications of postoperative stability, evaluated by stress radiography
   Clin Biomech (Bristol, Avon), 4 (1), 41-4
   DOI 10.1016/0268-0033(89)90066-1, PubMed 23915958
5. Scheifele D, Bjornsen GL, Arcand T, Jacobsen K (1989)
   Antigenuria after receipt of Haemophilus b diphtheria toxoid conjugate vaccine
   Pediatr Infect Dis J, 8 (12), 887-8
   DOI 10.1097/00006454-198912000-00014, PubMed 2626290
6. Scheuch CH, Berndt CH, Gross J, Poulsen JP, Saugstad DO, Haberland A (1989)
   Influence of the hypoxanthine/xanthine oxidase system on striatal (3H) dopamine uptake
   Biomed Biochim Acta, 48 (2-3), S212-6
   PubMed 2730611
7. Skinhøj P, Hofmann B, Jacobsen KD, Lerche B, Frederiksen B, Bygbjerg IC, Petersen CS, Dickmeiss E, Svejgaard A (1989)
   Independent clinical significance of HIV antigen determination and CD4 counts in anti-HIV positive patients
   Scand J Infect Dis, 21 (2), 149-53
   DOI 10.3109/00365548909039962, PubMed 2786246

Publications 1988

1. Jacobsen K (1988)
   [Penicillin in status asthmaticus]
   Ugeskr Laeger, 150 (17), 1058-9
   PubMed 3376245
2. Osmond DG, Jacobsen K, Park YH, Lamontagne L (1988)
   In vivo localization of B lymphocyte progenitor cells in mouse bone marrow
   Adv Exp Med Biol, 237, 45-51
   DOI 10.1007/978-1-4684-5535-9_5, PubMed 3267059
3. Osmond DG, Park YH, Jacobsen K (1988)
   B cell precursors in bone marrow: in vivo proliferation, localization, stimulation by activated macrophages and implications for oncogenesis
   Curr Top Microbiol Immunol, 141, 2-10
   DOI 10.1007/978-3-642-74006-0_1, PubMed 3265088
4. Scharff O, Foder B, Thastrup O, Hofmann B, Møller J, Ryder LP, Jacobsen KD, Langhoff E, Dickmeiss E, Christensen SB (1988)
   Effect of thapsigargin on cytoplasmic Ca2+ and proliferation of human lymphocytes in relation to AIDS
   Biochim Biophys Acta, 972 (3), 257-64
   DOI 10.1016/0167-4889(88)90200-5, PubMed 3143423
5. Watt-Boolsen S, Jacobsen K, Blichert-Toft M (1988)
   Total mastectomy with special reference to surgical technique, extent of axillary dissection and complications
   Acta Oncol, 27 (6A), 663-5
   DOI 10.3109/02841868809091765, PubMed 3219219

Publications 1987

1. Andersen JH, Jacobsen K (1987)
   [The occupational environment and health of seamstresses. A cross-sectional study of neck, shoulder and arm symptoms in seamstresses in the textile industry]
   Ugeskr Laeger, 149 (11), 746-8
   PubMed 3495060
2. Jacobsen K (1987)
   [Africa or AIDS?]
   Ugeskr Laeger, 149 (33), 2236-7
   PubMed 3450041
3. Jacobsen K (1987)
   [Working environment. If we had democracy nobody would become worn out from work. Interview by Ulla Danielsen]
   Sygeplejersken, 87 (4), 36-7
   PubMed 3647644

Publications 1985

1. Craig EA, Jacobsen K (1985)
   Mutations in cognate genes of Saccharomyces cerevisiae hsp70 result in reduced growth rates at low temperatures
   Mol Cell Biol, 5 (12), 3517-24
   DOI 10.1128/mcb.5.12.3517-3524.1985, PubMed 3915778
2. Hede A, Hejgaard N, Sandberg H, Jacobsen K (1985)
   Sports injuries of the knee ligaments--a prospective stress radiographic study
   Br J Sports Med, 19 (1), 8-10
   DOI 10.1136/bjsm.19.1.8, PubMed 3995236
3. Jacobsen K, Iversen BF (1985)
   A simple rig for stress radiography of the knee
   J Med Eng Technol, 9 (6), 277-80
   DOI 10.3109/03091908509032112, PubMed 4087282
4. Jacobsen K, Vopalecky F (1985)
   Congenital dislocation of the knee
   Acta Orthop Scand, 56 (1), 1-7
   DOI 10.3109/17453678508992968, PubMed 3984696

Publications 1984

1. Craig EA, Jacobsen K (1984)
   Mutations of the heat inducible 70 kilodalton genes of yeast confer temperature sensitive growth
   Cell, 38 (3), 841-9
   DOI 10.1016/0092-8674(84)90279-4, PubMed 6386178
2. Hejgaard N, Sandberg H, Hede A, Jacobsen K (1984)
   The course of differently treated isolated ruptures of the anterior cruciate ligament as observed by prospective stress radiography
   Clin Orthop Relat Res (182), 236-41
   PubMed 6692618
3. Wiholm BE, Asberg M, Jacobsen K, Boman G, Gahrton G (1984)
   A rating scale for emotional distress in patients with malignant diseases
   Acta Psychiatr Scand, 70 (4), 378-88
   DOI 10.1111/j.1600-0447.1984.tb01223.x, PubMed 6496161

Publications 1983

1. Hejgaard N, Sandberg H, Hede A, Jacobsen K (1983)
   Prospective stress radiography in 38 old injuries of the ligaments of the knee joint
   Acta Orthop Scand, 54 (1), 119-25
   DOI 10.3109/17453678308992880, PubMed 6829276
2. Hejgaard N, Sandberg H, Hede A, Jacobsen K (1983)
   [Injuries of the knee ligaments. A prospective and gonylaxometric study of 100 patients]
   Ugeskr Laeger, 145 (13), 988-91
   PubMed 6857808

Publications 1982

1. Gustafsson LL, Schildt B, Jacobsen K (1982)
   Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden
   Br J Anaesth, 54 (5), 479-86
   DOI 10.1093/bja/54.5.479, PubMed 6896150
2. Hejgaard N, Sandberg H, Hede A, Skive L, Jacobsen K (1982)
   Prospective stress radiographic study of knee ligament injuries in 62 patients treated by acute repair
   Acta Orthop Scand, 53 (2), 285-90
   DOI 10.3109/17453678208992217, PubMed 7136578
3. Ibsen KK, Hansen B, Jensen J, Klebak S, Merrick J, Michelsen N, Poulsen JP, Uldall P, Zachau-Christiansen B (1982)
   [Social pediatrics in Denmark today]
   Ugeskr Laeger, 144 (1), 48-53
   PubMed 7064246
4. Jacobsen K, Gintz T, Reed SM, Newbry J, Bayly WM, Perryman LE, Leid RW (1982)
   Isolation of equine neutrophils and analysis of functional characteristics by chemiluminescence and bacterial assays
   Am J Vet Res, 43 (11), 1912-6
   PubMed 7181189
5. Jacobsen K, Strange P (1982)
   [Chronic subdural hematoma in senescence. A retrospective study of the clinical picture in 42 patients]
   Ugeskr Laeger, 144 (11), 785-8
   PubMed 7101506
6. Nielsen RV, Hyldig-Nielsen F, Jacobsen K (1982)
   Biological properties of ristocetin-ps-aglycone
   J Antibiot (Tokyo), 35 (11), 1561-4
   DOI 10.7164/antibiotics.35.1561, PubMed 7161195

Publications 1981

1. Jacobsen K (1981)
   Gonylaxometry. Stress radiographic measurement of passive stability in the knee joints of normal subjects and patients with ligament injuries. Accuracy and range of application
   Acta Orthop Scand Suppl, 194, 1-263
   PubMed 6945792

Publications 1979

1. Sørensen K, Nielsen J, Busch P, Hamborg-Petersen B, Hansen E, Lassen LB, Nielsen K, Poulsen JP, Rossen K, Schaap SK, Taudorf K, Thelle T, Vestermark S, Vrang C (1979)
   [Measurement of testicular volume with Prader's orchiometer in 1,389 boys 5--15 1/2 years old]
   Ugeskr Laeger, 141 (14), 915-8
   PubMed 425192

Publications 1978

1. Jacobsen K (1978)
   Demonstration of rotatory instability in injured knees by stress radiography
   Acta Orthop Scand, 49 (2), 195-204
   DOI 10.3109/17453677809005751, PubMed 676706

Publications 1977

1. Bergman U, Jacobsen K, Wiholm BE (1977)
   [Drug handling in inpatient care -- safety and clinical viewpoints]
   Lakartidningen, 74 (21), 2098-2101
   PubMed 865180
2. Gyntelberg F, Jacobsen K, Martlev A, Backer P (1977)
   [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine]
   Ugeskr Laeger, 139 (11), 641-6
   PubMed 320734
3. Jacobsen K (1977)
   Osteoarthrosis following insufficiency of the cruciate ligaments in man. A clinical study
   Acta Orthop Scand, 48 (5), 520-6
   DOI 10.3109/17453677708989742, PubMed 596150
4. Jacobsen K (1977)
   Radiologic technique for measuring instability in the knee joint
   Acta Radiol Diagn (Stockh), 18 (1), 113-25
   DOI 10.1177/028418517701800115, PubMed 878886
5. Jacobsen K (1977)
   Stress radiographical measurements of post-traumatic knee instability. A clinical study
   Acta Orthop Scand, 48 (3), 301-10
   DOI 10.3109/17453677708988773, PubMed 920123
6. Jacobsen K, Holst-Nielsen F (1977)
   A modified McCash operation for Dupuytren's contracture
   Scand J Plast Reconstr Surg, 11 (3), 231-3
   DOI 10.3109/02844317709025523, PubMed 609907
7. Jacobsen K, Rosenkilde P (1977)
   A clinical and stress radiographical follow-up investigation after Jones' operation for replacing the anterior cruciate ligament
   Injury, 8 (3), 221-6
   DOI 10.1016/0020-1383(77)90135-8, PubMed 881255

Publications 1976

1. Askestig G, Bergman U, Jacobsen K, Wiholm BE (1976)
   [Needless safety risks in nursing]
   Tidskr Sver Sjukskot, 43 (5), 8
   PubMed 1045652
2. Bergman U, Jacobsen K, Wiholm BE (1976)
   [Handling of drugs in inpatient care--experiences from a comparison between 2 systems of drug recording]
   Tidskr Sver Sjukskot, 43 (17), 46-51
   PubMed 1051083
3. Jacobsen K (1976)
   Landmarks of the knee joint of the lateral radiograph during rotation
   Rofo, 125 (5), 399-404
   DOI 10.1055/s-0029-1230488, PubMed 137183
4. Jacobsen K (1976)
   Stress radiographical measurement of the anteroposterior, medial and lateral stability of the knee joint
   Acta Orthop Scand, 47 (3), 335-4
   DOI 10.3109/17453677608992002, PubMed 952223
5. Jacobsen K, Metz P (1976)
   Occult traumatic dislocation of the patella
   J Trauma, 16 (10), 829-35
   DOI 10.1097/00005373-197610000-00015, PubMed 994264

Publications 1975

1. Jacobsen K, Tondevold E (1975)
   [Hemarthrosis of the knee. Emergency treatment, diagnosis and referral]
   Ugeskr Laeger, 137 (47), 2759-61
   PubMed 1189095
2. Kamper-Jorgensen F, Albertsen J, Almind G, Andersen K, Braae M, Dybkjaer L, Frolund F, Granlie K, Hald E, Hald J, Hector O, Jacobsen K, Kaltoft S, Kjaerulff E, Mabeck CD, Magnusson B, Nielsen A, Novella P, Olsen OM, Pedersen PA, Rasmussen I, Strunk K, Traeden JB, Veje JO (1975)
   [Withdrawal of high estrogen containing oral contraceptives and the demand for medical service]
   Ugeskr Laeger, 137 (13), 759-62
   PubMed 1135973

Publications 1974

1. Jacobsen K (1974)
   [Coding of patients in general practice]
   Ugeskr Laeger, 136 (38), 2168-70
   PubMed 4408959
2. Jacobsen K (1974)
   Area intercondylaris tibiae: Osseous surface structure and its relation to soft tissue structures and applications to radiography
   J Anat, 117 (Pt 3), 605-18
   PubMed 4479327
3. Jacobsen K (1974)
   [Unemployment and dismissal as disease-producing factors. A review and discussion]
   Ugeskr Laeger, 136 (29), 1650-2
   PubMed 4844777
4. Jacobsen K, Bertheussen K (1974)
   The vertical location of the patella. Fundamental views on the concept patella alta, using a normal sample
   Acta Orthop Scand, 45 (3), 436-45
   DOI 10.3109/17453677408989166, PubMed 4407009
5. Jacobsen K, Bertheussen K, Gjerloff CC (1974)
   Characteristics of the line of Blumensaat. An experimental analysis
   Acta Orthop Scand, 45 (5), 764-71
   DOI 10.3109/17453677408989687, PubMed 4451079
6. Jacobsen K, Jensen LB (1974)
   The Dodd-Cockett operation. An analysis of the long-term prognosis
   Acta Chir Scand, 140 (5), 379-84
   PubMed 4855162
7. Jacobsen K, Strunk KW (1974)
   [Letter: Cardiac ambulances or armamentarium for the practitioning physician?]
   Ugeskr Laeger, 136 (47), 2623-5
   PubMed 4446087
8. Strunk KW, Jacobsen K (1974)
   [The acute seriously ill patient in general practice and the role of the general practitioner]
   Ugeskr Laeger, 136 (31), 1746-50
   PubMed 4411117

Publications 1973

1. Hals E, Björlin G, Jacobsen K (1973)
   Histopathological changes in rat incisors in experimental carbon tetrachloride intoxication
   Odontol Revy, 24 (1), 5-26
   PubMed 4514064
2. Haram K, Jacobsen K (1973)
   Measles and its relationship to giant cell pneumonia (Hecht pneumonia)
   Acta Pathol Microbiol Scand A, 81 (6), 761-9
   DOI 10.1111/j.1699-0463.1973.tb03569.x, PubMed 4129855
3. HARAM K, JACOBSEN K (1973)
   MEASLES AND ITS RELATIONSHIP TO GIANT-CELL PNEUMONIA (HECHT PNEUMONIA)
   ACTA PATH MICRO IM A, A 81 (6), 761-769
4. Holstein P, Jacobsen K, Pedersen JF, Sorensen JS (1973)
   Intravesical hydrostatic pressure treatment: new method for control of bleeding from the bladder mucosa
   J Urol, 109 (2), 234-6
   DOI 10.1016/s0022-5347(17)60394-x, PubMed 4685733
5. Jacobsen K (1973)
   [The vulnerable individual--a pilot study]
   Ugeskr Laeger, 135 (48), 2655-61
   PubMed 4782914

Publications 1972

1. Jacobsen K (1972)
   [Dismissal and morbidity]
   Ugeskr Laeger, 134 (7), 352-4
   PubMed 5015557
2. Jacobsen K (1972)
   [Vulnerability illustrated from general practice]
   Ugeskr Laeger, 134 (24), 1299-303
   PubMed 5047068
3. Jacobsen K (1972)
   [The notion of vulnerability. Review and discussion]
   Ugeskr Laeger, 134 (3), 115-8
   PubMed 5061583

Publications 1971

1. Jacobsen K (1971)
   [Life change measurement. A review]
   Ugeskr Laeger, 133 (41), 2042-4
   PubMed 5128555

Publications 1970

1. Andersen PT, Jacobsen K (1970)
   [Explorative arthrotomy as a means of diagnosis of meniscal lesions, joint mice and osteochondritis dissecans of the knee joint]
   Ugeskr Laeger, 132 (42), 1970-4
   PubMed 5474087

Publications 1968

1. Jacobsen K, Carstens PH (1968)
   [Prophylactic use of propranolol in acute coronary occlusion. A double-blind study]
   Ugeskr Laeger, 130 (22), 936-9
   PubMed 4880860

Publications 1967

1. Carstens PH, Jacobsen K (1967)
   [Corticosteroid treatment of heart block with coronary occlusion]
   Ugeskr Laeger, 129 (6), 198-200
   PubMed 5599212

Publications 1964

1. JACOBSEN K (1964)
   [THE ALCOHOL PROBLEM AND INDUCED ABORTION]
   Ugeskr Laeger, 126, 409-12
   PubMed 14142335

Publications 1952

1. JACOBSEN K (1952)
   [Desoxycorticosterone administration in reconvalescence after electroshock]
   Nord Med, 48 (42), 1448-9
   PubMed 13025849

Publications 1951

1. JACOBSEN K (1951)
   [Effect of synacur, a decamethonium simulant, in electroshock therapy]
   Nord Med, 46 (44), 1635-8
   PubMed 14899764